Back to comparisons

Comparison

Bacopa Monnieri vs Chaga

FieldBacopa MonnieriChaga
Categoryadaptogenadaptogen
Dose range300–600mg1000–3000mg
Half-life4h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs540280

The comparison in plain English

Auto-generated from data

Bacopa Monnieri and Chaga are both in the adaptogen category respectively. Bacopa Monnieri Ayurvedic herb (Bacopa monnieri) with the strongest natural-nootropic evidence base for memory acquisition and retention. Chaga Birch-tree mushroom (Inonotus obliquus) traditionally used in Russia/Siberia for immune and antioxidant support.

Bottom line

Bacopa Monnieri (evidence A, safety 5/5) has a weaker evidence base than Chaga (evidence B, safety 4/5). Bacopa Monnieri has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Bacopa Monnieri if

Bacopa Monnieri is the better fit when your goal aligns with its mechanism (Active bacosides A and B increase dendritic branching in the CA3 region of the hippocampus, the structural change that underlies improved memory consolidation) and the dose range (300–600mg) suits your protocol. Half-life is 4h.

Choose Chaga if

Chaga is the better fit when your goal aligns with its mechanism (Polysaccharides (beta-glucans), betulinic acid (from the birch tree the fungus grows on), and melanin compounds contribute to antioxidant and immunomodulatory effects) and the dose range (1000–3000mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →